Search Ontology:
ChEBI
beta-D-GalpNAc-(1->4)-[alpha-Neup5Ac-(2->3)]-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp
- Term ID
- CHEBI:190921
- Synonyms
-
- 2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1->6)-[5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)]-beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-beta-D-galactopyranose
- alpha-Neu5Ac-(2->3)-[beta-D-GalNAc-(1->6)]-beta-D-Gal-(1->3)-beta-D-GlcNAc-(1->3)-beta-D-Gal
- beta-D-GalNAc-(1->6)-[alpha-Neu5Ac-(2->3)]-beta-D-Gal-(1->3)-beta-D-GlcNAc-(1->3)-beta-D-Gal
- GalNAcbeta1-6(Neu5Acalpha2-3)Galbeta1-3GlcNAcbeta1-3Galbeta
- N-acetyl-alpha-neuraminyl-(2->3)-[N-acetyl-beta-D-galactosaminyl-(1->6)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactose
- N-acetyl-beta-D-galactosaminyl-(1->6)-[N-acetyl-alpha-neuraminyl-(2->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactose
- Neu5Acalpha2-3(GalNAcbeta1-6)Galbeta1-3GlcNAcbeta1-3Galbeta
- Definition
- A branched amino pentasaccharide comprising a chain of α-N-acetylneuraminyl, β-D-galactosyl, N-acetyl-β-D-glucosaminyl and β-D-galactose residues linked sequentially (2→3), (1→3) and (1→3), to the D-galactosyl residue distal to the reducing end is also attached an N-acetyl-β-D-glucosaminyl residue of which is also attached via a β(1→6) linkage an N-acetyl-D-galactosyl residue. A 5-aminopentyl linker may be attached to the oxygen at position 1 of the reducing-end galactose residue.
- References
-
- pubmed:23819648
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from beta-D-GalpNAc-(1->4)-[alpha-Neup5Ac-(2->3)]-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp
Phenotype where environments contain beta-D-GalpNAc-(1->4)-[alpha-Neup5Ac-(2->3)]-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp
Phenotype modified by environments containing beta-D-GalpNAc-(1->4)-[alpha-Neup5Ac-(2->3)]-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp
Phenotype affecting beta-D-GalpNAc-(1->4)-[alpha-Neup5Ac-(2->3)]-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp
Human Disease Model